aTyr Raises $10.5 Million

aTyr Pharma, a San Diego-based drug company focused on developing a novel class of naturally-occurring protein biologics for therapeutic application, has raised $10.5 million in Series B funding. Alta Partners and Polaris Venture Partners co-led the round, which also included Imagene and return backer Cardinal Partners. www.atyrpharma.com